Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG171 Tablets

NCT05668897 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: GST-HG171
DRUG: placebo of GST-HG171

Sponsor

Fujian Akeylink Biotechnology Co., Ltd.